1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
DOD Peer Reviewed Alzheimer's Research Program FY25 is sponsored by U.S. Army Medical Research and Development Command (USAMRDC). Anticipated funding for impactful, solution-oriented research to address critical needs and improve the quality of life for Service Members, Veterans, their Families, and the public living with Alzheimer's disease (AD) and related dementias (ADRD).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DOD Peer Reviewed Alzheimer's Research Program FY25 | Research And Engagement Research And Engagement > Scholar Updates > DOD Peer Reviewed Alzheimer’s Research Program FY25 DOD Peer Reviewed Alzheimer’s Research Program FY25 Posted on December 12, 2024 Applications submitted to the FY25 PRARP must be relevant to one or more of the following priority areas: Reduce Risk and Prevent AD/ADRD Improve Diagnosis and Prognosis Improve Quality of Life for People Living With a Dementia Diagnosis In addition, the PRARP is interested in work that addresses and reduces health disparities in AD/ADRD research.
All FY25 PRARP mechanisms have a Career Initiation or Transition (CIT) Partnership Option to encourage research capacity in critical areas to include women’s health, military health and dementia care. The partnership option allows for two investigators with complementary research expertise to work collaboratively on one project. One investigator must meet the definition of Career Initiation or Career Transition.
For this option, the CIT investigator should have only nominal research support in the field and be either : (a) Career Initiation: a junior investigator three or more years from their terminal degree but no more than seven years into an independent position (b) Career Transition: transitioning from another field to the AD/ADRD/TBI field and has only nominal, if any, publications in the AD-related field.
The PI must be an independent investigator at any career level. Supports person-centered research that prioritizes both the individual with AD/ADRD and their care partner(s). The project should clearly demonstrate feasibility and a realistic approach to scaling and implementation.
“Care” does not refer to medical care (such as medical interventions administered by a physician) but is inclusive of all modalities and requirements of dementia care. There is no requirement for studies to be performed in a Veteran or military cohort. The PRARP encourages investigators to consider how their research from a civilian cohort might be applicable to such populations, and vice versa.
Community collaboration is required for all applications. Animal studies are not allowed. Clinical trials are allowed.
The CIT Option is available. Submission of a preproposal is required; application submission is by invitation only. Maximum funding of $1.
6 million (M) for total costs. Maximum period of performance is 4 years. Maximum funding of $1.
8M for total costs Transforming Diagnosis Award The PI must be an independent investigator at any career level. Supports research to reduce barriers and improve diagnosis and prognosis of dementia of AD/ADRD following military service and/or TBI. There is no requirement for studies to be performed in a Veteran or military cohort.
The PRARP encourages investigators to consider how their research from a civilian cohort might be applicable to such populations, and vice versa. Studies leveraging existing cohorts or data sets are encouraged. Community collaboration is required for all applications.
The CIT Option is available. Animal studies are not allowed. Submission of a preproposal is required; application submission is by invitation only Maximum funding of $1.
5M for total costs. Maximum period of performance is 4 years. Maximum funding of $1.
7M for total costs Transforming Research Award The PI must be an independent investigator at any career level. Research must address the priority area of “Reduce risk and prevent AD/ADRD. ” Supports high-impact research aimed to identify, validate, and/or mitigate risk factors that may contribute to dementia onset.
Clinical trials are not supported, but studies with prospective human subjects’ enrollment may be allowed. Applications proposing clinical studies will require community collaboration. Studies leveraging existing cohorts or data sets are encouraged.
Animal studies that are fully justified for relevance to human health are allowed. Community collaboration is not required for projects that focus primarily on animal studies but is encouraged. The CIT Option is available.
Submission of a preproposal is required; application submission is by invitation only. Maximum funding of $1. 0M for total costs.
Maximum period of performance is 3 years. Maximum funding of $1. 0M for total costs usarmy.
detrick. medcom-cdmrp. mbx.
cdmrp-public-affairs@health. mil Taken from the official pre-announcement email on 12/6/25 Community and Therapeutic Recreation Masters Student Wins National Scholarship Masters student Camrahn Jamison is the recipient of one of two 2026 National Student Scholarship Awards from the National Recreation...
Answering a New Call to Serve: Veteran’s Path to Educational Leadership From the U.S. Army to the classroom, Tyler Bacote’s journey is a powerful reminder that education can transform lives. Through men... How Bryan School Professor is Rewriting Narrative on Workplace Trauma Inspired by stories from her loved ones and coworkers, Dr. Madelynn Stackhouse now helps businesses better understand how stress and...
According to the current listing, eligibility includes: Independent investigators at any career level (for Transforming Diagnosis Award). Community collaboration is required for all applications. Pre-application is required. Confirm the full requirements in the official notice before applying.
DOD Peer Reviewed Alzheimer's Research Program FY25 is funded by U.S. Army Medical Research and Development Command (USAMRDC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleAFOSR's open Broad Agency Announcement — the single front door to Air Force basic research funding — closed on March 23, 2026 for mandatory review under Executive Order 14332, and proposals submitted in its final week must be resubmitted to a replacement that has no posted date. Meanwhile NRL's Long Range BAA takes white papers only through September 30, and the Air Force's new $99 million command-and-control BAA runs to 2028 with a March 15, 2027 white paper date for FY28 money. A field guide to the rolling-solicitation channel while it is in flux.
Read articleAfter SBIR reauthorization, the U.S. Army released five new small-business topics under Army FUZE — Ka-Band metamaterial radar, a Li-ion 6T battery open topic, in-transit-visibility blockchain, modular UAS payloads, and the xTech|Phantum prize competition. Awards run from $150K to $300K per Phase I. But the bigger story is the Army's shift from funding parts to funding whole systems. Here is what each topic funds and how to compete.
Read article